sleep apnea tirzepatide Reduced in People Who Took Zepbound, Eli Lilly Reports Tirzepatide for the Treatment of

Researchers found that the difference in the time it took for half of ingested food to move from the stomach to the small intestine was just 36 minutes longer for patients taking GLP-1 medications, a relatively small amount of time compared to the standard periprocedural fasting period of eight hours

We will be following all this and more, so make sure you are subscribed to our emails for alerts!

Still, a few risks deserve attention: Scalp irritation

The cardiovascular benefits appeared most pronounced in patients who achieved the greatest weight loss

As a dual GIP and GLP-1 receptor agonist, this innovative treatment not only enhances insulin secretion but also curbs appetite and slows gastric emptying, leading to impressive weight loss results